Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ahmad Younes , Guilherme Ferragut Attizzani , Ankur Kalra Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1 As… View more

Vascular Disease and Surgery

Intervention
Transcatheter Therapies for Tricuspid Valve Repair and Replacement
Author(s): Kusha Rahgozar , Sharon Bruoha , Edwin C Ho , et al Added: 2 years ago

Intervention
USC Discussion 2022: Transcatheter Aortic Valve Replacement Optimization Strategies
Author(s): Hemal Gada , Kendra J Grubb Added: 1 year ago
Dr Hemal Gada (UPMC Heart and Vascular Institute, US) and his team published an informative review article on “Transcatheter Aortic Valve Replacement Optimization Strategies: Cusp Overlap, Commissural Alignment, Sizing, and Positioning”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited byDr Kendra Grubb(Emory Structural Heart and Valve… View more

Vascular Disease and Surgery

Intervention
Updates from the New Heart Valve Patient.com National Survey Data
Author(s): Kendra J Grubb Added: 3 years ago
Dr Kendra Grubb (Emory University, Atlanta, GA, US)discusses recent results from the new Heart Valve Patient National Survey and her take on how can cardiologists efficiently engage heart valve patients in decisions about their treatment. Questions: 1.What was the rationale for the New Heart Valve Patient National Survey? 2.What were the aims of the survey and key areas of investigation? 3… View more

Vascular Disease and Surgery

Intervention
AVATAR: AVR Vs Watchful Waiting in Asymptomatic Severe AS
Author(s): Marko Banovic Added: 2 years ago
In this short video interview, Dr Marko Banovic (Clinical centre of Serbia, Belgrade, RS) discusses the AVATAR Trial. The trial evaluated aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis. Presented first at AHA 2021, the trial showed that early AVR was beneficial at preventing adverse events among patients with asymptomatic… View more

Vascular Disease and Surgery

Intervention
Effect of the Extent of Cardiac Damage on Transcatheter Aortic Valve Replacement Outcome: A New Aortic Stenosis Staging System
Author(s): Miho Fukui , João L Cavalcante Added: 3 years ago
Degenerative calcific aortic stenosis (AS) is one of the most common valvular heart diseases, affecting >3% of those aged >65 years in the West.1 As a result of an aging population, the prevalence of AS is expected to increase. Severe AS causes chronic pressure overload of the left ventricle (LV), resulting in LV hypertrophy (LVH), diastolic dysfunction, an increase in the size of the left… View more

Vascular Disease and Surgery

Imaging & Diagnostics
TAVR Optimization
Author(s): Saima Siddique , Resha Khanal , Amit N Vora , et al Added: 2 years ago

Vascular Disease and Surgery

Intervention
TCT 22: Sentinel® Stroke Protection System During TAVR
Author(s): Samir R Kapadia Added: 1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement. In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention… View more

Prevention & Chronic Conditions

Intervention
ACC.24: The DEDICATE Trial
Author(s): Moritz Seiffert Added: 1 week ago
ACC.24 — Investigator Dr Moritz Seiffert (University Heart and Vascular Center Hamburg, DE) joins us onsite at ACC to discuss the findings of the DEDICATE-DZHK6 Trial (NCT03112980).This randomized controlled, multi-center trial aimed to investigate whether transcatheter aortic valve implantation (TAVI) is non-inferior to surgical aortic valve replacement (SAVR) in patients with symptomatic severe… View more

Intervention
Who should be referred for TAVR
Author(s): Colin M Barker , Michael J Reardon Added: 3 years ago
Aortic stenosis (AS) has a long latent period and then rapid progression with high mortality once symptoms appear.1 The absence of an effective medical therapy for symptomatic severe AS led to a class I indication for aortic valve replacement (AVR) in both the US and European guidelines.2,3 Unfortunately, a study by Bach et al. in 2009 found that up to half of patients with symptomatic severe AS… View more

Vascular Disease and Surgery

Intervention